These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

985 related articles for article (PubMed ID: 23940645)

  • 1. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults.
    Weir TL; Manter DK; Sheflin AM; Barnett BA; Heuberger AL; Ryan EP
    PLoS One; 2013; 8(8):e70803. PubMed ID: 23940645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differences between colorectal cancer patients and healthy people in fecal microbiota and metabolites].
    Wang X; Wang J; Rao B; Deng L; Huang Y; Zeng G; Chen C
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Nov; 18(11):1106-10. PubMed ID: 26616803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
    Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
    Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
    [No Abstract]   [Full Text] [Related]  

  • 4. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
    Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
    Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
    Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer.
    Xi Y; Yuefen P; Wei W; Quan Q; Jing Z; Jiamin X; Shuwen H
    J Transl Med; 2019 Oct; 17(1):353. PubMed ID: 31665031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.
    Song EM; Byeon JS; Lee SM; Yoo HJ; Kim SJ; Lee SH; Chang K; Hwang SW; Yang DH; Jeong JY
    Dig Dis Sci; 2018 May; 63(5):1229-1236. PubMed ID: 29516324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer.
    Ohigashi S; Sudo K; Kobayashi D; Takahashi O; Takahashi T; Asahara T; Nomoto K; Onodera H
    Dig Dis Sci; 2013 Jun; 58(6):1717-26. PubMed ID: 23306850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
    Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
    Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolite profile comparisons between ascending and descending colon tissue in healthy adults.
    Baxter BA; Parker KD; Nosler MJ; Rao S; Craig R; Seiler C; Ryan EP
    World J Gastroenterol; 2020 Jan; 26(3):335-352. PubMed ID: 31988593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients.
    Sánchez-Alcoholado L; Laborda-Illanes A; Otero A; Ordóñez R; González-González A; Plaza-Andrades I; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Navy Beans Impact the Stool Metabolome and Metabolic Pathways for Colon Health in Cancer Survivors.
    Baxter BA; Oppel RC; Ryan EP
    Nutrients; 2018 Dec; 11(1):. PubMed ID: 30583518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers.
    Hale VL; Jeraldo P; Chen J; Mundy M; Yao J; Priya S; Keeney G; Lyke K; Ridlon J; White BA; French AJ; Thibodeau SN; Diener C; Resendis-Antonio O; Gransee J; Dutta T; Petterson XM; Sung J; Blekhman R; Boardman L; Larson D; Nelson H; Chia N
    Genome Med; 2018 Oct; 10(1):78. PubMed ID: 30376889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
    Chen R; Wang J; Zhan R; Zhang L; Wang X
    J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations.
    Sinha R; Ahn J; Sampson JN; Shi J; Yu G; Xiong X; Hayes RB; Goedert JJ
    PLoS One; 2016; 11(3):e0152126. PubMed ID: 27015276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stool pattern is associated with not only the prevalence of tumorigenic bacteria isolated from fecal matter but also plasma and fecal fatty acids in healthy Japanese adults.
    Watanabe D; Murakami H; Ohno H; Tanisawa K; Konishi K; Todoroki-Mori K; Tsunematsu Y; Sato M; Ogata Y; Miyoshi N; Kubota N; Kunisawa J; Wakabayashi K; Kubota T; Watanabe K; Miyachi M
    BMC Microbiol; 2021 Jun; 21(1):196. PubMed ID: 34182940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
    Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
    Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool.
    Brown DG; Rao S; Weir TL; O'Malia J; Bazan M; Brown RJ; Ryan EP
    Cancer Metab; 2016; 4():11. PubMed ID: 27275383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer.
    Zhang C; Hu A; Li J; Zhang F; Zhong P; Li Y; Li Y
    Front Cell Infect Microbiol; 2022; 12():830684. PubMed ID: 35663463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat-stabilised rice bran consumption by colorectal cancer survivors modulates stool metabolite profiles and metabolic networks: a randomised controlled trial.
    Brown DG; Borresen EC; Brown RJ; Ryan EP
    Br J Nutr; 2017 May; 117(9):1244-1256. PubMed ID: 28643618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.